Operating Lease, Right-of-Use Asset of CorMedix Inc. from 02 Jan 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
CorMedix Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 02 Jan 2019 to 30 Sep 2025.
  • CorMedix Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $3,173,567, a 498% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

CorMedix Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $3,173,567 +$2,642,705 +498% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $413,652 -$154,516 -27% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $453,633 -$151,001 -25% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $492,697 -$147,581 -23% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q3 2024 $530,862 -$144,254 -21% 30 Sep 2024 10-Q 30 Oct 2024 2024 Q3
Q2 2024 $568,168 -$141,017 -20% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $604,634 -$137,869 -19% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $640,278 -$134,807 -17% 31 Dec 2023 10-K 25 Mar 2025 2024 FY
Q3 2023 $675,116 -$131,830 -16% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $709,185 -$128,936 -15% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $742,503 -$126,644 -15% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $775,085 -$124,420 -14% 31 Dec 2022 10-K 12 Mar 2024 2023 FY
Q3 2022 $806,946 -$122,260 -13% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $838,121 -$120,164 -13% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $869,147 -$117,610 -12% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $899,505 -$115,130 -11% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 $929,206 -$112,785 -11% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $958,285 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $986,757 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 $1,014,635 +$1,009,945 +21534% 31 Dec 2020 10-K 29 Mar 2022 2021 FY
Q3 2020 $1,041,991 +$1,036,991 +20740% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q4 2019 $4,690 -$1,310 -22% 31 Dec 2019 10-K 30 Mar 2021 2020 FY
Q3 2019 $5,000 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q4 2018 $6,000 02 Jan 2019 10-K 16 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.